Bod Australia Limited Stocks

A$ 0Last Updated 23.03.2026

Issuer Rating

Performance

Modest

Risk

Negligible

Recommendation

Sell

Buy
Review
Evaluation
Target price
Dynamics
Performance
Growth
Dividends
Risks
A$ 0
Key Takeaways

Risk factor

Moderate default risk

Profitability factor

Strong growth

Data is available to registered users only
Data is available to registered users only
Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

About

Bod Australia Limited engages in the development and manufacture of cannabidiol (CBD) and hemp products in Australia, the United Kingdom, and internationally. The company operates through three segments: Medical, OTC CBD/Hemp, and OTC Herbals. It also develops, manufactures, and distributes therapeutics medicinal cannabis products. The company was incorporated in 2014 and is based in Double Bay, Australia.

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis
X-channel

Buy

Sell

0 more stocks